(19)
(11) EP 2 046 331 A1

(12)

(43) Date of publication:
15.04.2009 Bulletin 2009/16

(21) Application number: 07811048.3

(22) Date of filing: 02.08.2007
(51) International Patent Classification (IPC): 
A61K 31/454(2006.01)
A61K 45/06(2006.01)
A61K 39/395(2006.01)
A61P 35/00(2006.01)
(86) International application number:
PCT/US2007/017343
(87) International publication number:
WO 2008/019065 (14.02.2008 Gazette 2008/07)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR MK RS

(30) Priority: 03.08.2006 US 835752 P

(71) Applicant: CELGENE CORPORATION
Summit, NJ 07901 (US)

(72) Inventor:
  • ZELDIS, Jerome, B.
    Princeton, NJ 08540 (US)

(74) Representative: Ritter, Thomas Kurt et al
Jones Day Prinzregentenstraße 11
80538 München
80538 München (DE)

   


(54) USE OF 3- (4-AMINO-1-OXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE FOR THE TREATMENT OF MANTLE CELL LYMPHOMAS